Prognosis of patients suffering from acute respiratory distress syndrome (ARDS) is poor.
This is especially true for immunosuppressed patients. It is controverisal whether these …

Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the
survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still …

Extracorporeal membrane oxygenation (ECMO) use in acute respiratory failure is
increasing. We aim to compare characteristics and outcomes of patients with prolonged (≥ …

Objectives: Over the last decade, extracorporeal membrane oxygenation (ECMO) has
become a promising option for patients with severe acute respiratory distress syndrome …

Objective Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is increasingly
used to support patients with severe acute respiratory distress syndrome (ARDS). In case of …

Background: Although the use of extra-corporeal membrane oxygenation (ECMO) has been
rapidly increasing, the benefit of ECMO in patients with acute respiratory distress syndrome …

OBJECTIVES: To examine trends in utilization and outcomes among patients with the acute
respiratory distress syndrome (ARDS) requiring prolonged venovenous extracorporeal …

Objective: The immunoinflammatory response is central to the pathogenesis of acute
respiratory distress syndrome (ARDS). However, little is known how this is affected by …

Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a useful life support in
severe acute respiratory distress syndrome (ARDS). Although prolonged mechanical …

OBJECTIVES There are limited data regarding extracorporeal membrane oxygenation
(ECMO) support in immunocompromised patients, despite an increase in ECMO use in …